Geesthacht/Essen, Germany. Evonik’s new multi-purpose silicones manufacturing facility in Geesthacht, Germany is now fully operational after completing final commissioning tests and gaining the necessary authority approvals. Engineers carried out small batch runs, and the essential safety assessments required for production to start, despite the added complexity posed by the Covid-19 pandemic.
Following the inauguration in January, the new plant in Northern Germany, 30 kilometers outside Hamburg, is now producing the silicones and silyl-terminated polymers (SMP’s) used for example, in parquet adhesive flooring, liquid membranes for roofing or electronical potting applications. The extra production capacities will provide Evonik customers with a faster and more reliable supply of products, and a wider choice of products such as innovative nanotechnologies.
“Fortunately, we commissioned the facility’s new tank farm before the full impact of the Covid-19 virus was realized, but still had testing to do before we could be fully operational,” said Dr. Sabine Giessler-Blank, head of the Polymer & Construction Specialties Product Line. “I’m very proud of our team and our partners’ achievements – as we still managed to complete the project on schedule despite several additional safety measures.”
The new facility strengthens Evonik’s innovation capabilities and its focus on silicone and nanotechnology specialty chemical products. These include addition-curing silicones and the SMP’s used as binders for adhesives and sealants in parquet adhesives, adhesives for wound care and other medical applications or in electronics, for example in thermally conductive polymer filling compounds for e-mobility.
Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €13.1 billion and an operating profit (adjusted EBITDA) of €2.15 billion in 2019. Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. More than 32,000 employees work together for a common purpose: We want to improve life, today and tomorrow.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.